Novovax
- India
SII starts production of Covovax, CEO says it has ‘great potential’ for children
In a new move towards ensuring better inoculation, the Serum Institute of India (SII) has started the production of the first batch of the Novavax COVID-19 vaccine in India, dubbed Covovax. Novavax…
- World
SII partner Novavax’s COVID-19 shot 90% effective
Washington: US-based biotechnology company Novavax’s protein-based vaccine has shown overall 90 per cent efficacy against Covid-19, results of Phase-3 trials have shown. The vaccine NVX-CoV2373 is already being locally manufactured by the company’s…
